Healthcare provider profile · identity verified

Emily Ann Beck, NP

Nurse Practitioner · DURHAM, NC · NPI 1942973540

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	779	113
Amlodipine Besylate	Amlodipine Besylate	517	69
Levothyroxine Sodium	Levothyroxine Sodium	355	45
Famotidine	Famotidine	325	38
Mirtazapine	Mirtazapine	282	37
Trazodone Hcl	Trazodone Hcl	260	46
Losartan Potassium	Losartan Potassium	258	47
Furosemide	Furosemide	250	49
Lisinopril	Lisinopril	235	29
Gabapentin	Gabapentin	229	35
Donepezil Hcl	Donepezil Hcl	220	30
Metformin Hcl	Metformin Hcl	193	29
Memantine Hcl	Memantine Hcl	186	22
Sertraline Hcl	Sertraline Hcl	154	21
Metoprolol Succinate	Metoprolol Succinate	149	26
Potassium Chloride	Potassium Chloride	145	26
Pantoprazole Sodium	Pantoprazole Sodium	144	20
Clopidogrel	Clopidogrel Bisulfate	125	22
Eliquis	Apixaban	124	22
Escitalopram Oxalate	Escitalopram Oxalate	108	18
Metoprolol Tartrate	Metoprolol Tartrate	107	15
Quetiapine Fumarate	Quetiapine Fumarate	106	19
Rosuvastatin Calcium	Rosuvastatin Calcium	104	16
Olanzapine	Olanzapine	103	21
Omeprazole	Omeprazole	99	17
Tramadol Hcl	Tramadol Hcl	96	23
Carvedilol	Carvedilol	89	14
Divalproex Sodium	Divalproex Sodium	89	14
Citalopram Hbr	Citalopram Hydrobromide	80	15
Levetiracetam	Levetiracetam	80	14
Tamsulosin Hcl	Tamsulosin Hcl	80	18
Doxycycline Hyclate	Doxycycline Hyclate	79	50
Hydralazine Hcl	Hydralazine Hcl	76	15
Pregabalin	Pregabalin	75	11
Lorazepam	Lorazepam	72	25
Risperidone	Risperidone	71	15
Cephalexin	Cephalexin	70	53
Fluoxetine Hcl	Fluoxetine Hcl	70	13
Januvia	Sitagliptin Phosphate	70	11
Bupropion Xl	Bupropion Hcl	67	suppressed
Warfarin Sodium	Warfarin Sodium	66	suppressed
Bumetanide	Bumetanide	58	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	suppressed
Fluticasone Propionate	Fluticasone Propionate	57	15
Myrbetriq	Mirabegron	56	13
Simvastatin	Simvastatin	54	suppressed
Allopurinol	Allopurinol	49	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	suppressed
Duloxetine Hcl	Duloxetine Hcl	48	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	47	26
Pravastatin Sodium	Pravastatin Sodium	45	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	45	26
Hydrochlorothiazide	Hydrochlorothiazide	43	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	43	suppressed
Oxycodone Hcl	Oxycodone Hcl	41	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Nystatin	Nystatin	37	22
Lamotrigine	Lamotrigine	36	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Torsemide	Torsemide	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	29
Buspirone Hcl	Buspirone Hcl	33	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Clonazepam	Clonazepam	30	suppressed
Finasteride	Finasteride	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	12
Benztropine Mesylate	Benztropine Mesylate	23	suppressed
Divalproex Sodium Er	Divalproex Sodium	23	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Permethrin	Permethrin	22	13
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Lithium Carbonate	Lithium Carbonate	21	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	21	suppressed
Meloxicam	Meloxicam	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	15
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Valsartan	Valsartan	17	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Loperamide	Loperamide Hcl	16	11
Ramipril	Ramipril	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Ivermectin	Ivermectin	15	suppressed
Nystop	Nystatin	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Baclofen	Baclofen	14	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Phenytoin	Phenytoin	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Trimethoprim	Trimethoprim	13	suppressed
Atenolol	Atenolol	12	suppressed
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Lactulose	Lactulose	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Perphenazine	Perphenazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error